Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...
Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webinars presented every Wednesday for 8 weeks! At 7:45am PT meet our ...